Hzf and hCAS/CSE1L: making the right choice in p53-mediated tumour suppression

Cell Res. 2007 Oct;17(10):829-31. doi: 10.1038/cr.2007.85.

Authors

Katherine E Ewings¹, Kevin M Ryan

Affiliation

¹ Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Cancer Research UK Beatson Laboratories, Garscube Estate, Switchback Rd, Glasgow, G61 1BD, UK.

PMID: 17934491
DOI: 10.1038/cr.2007.85

No abstract available

MeSH terms

Animals
Apoptosis / genetics
Apoptosis / physiology
Cellular Apoptosis Susceptibility Protein / genetics
Cellular Apoptosis Susceptibility Protein / metabolism*
DNA Damage
DNA-Binding Proteins / genetics
DNA-Binding Proteins / metabolism*
Humans
Models, Biological
Neoplasms / genetics
Neoplasms / metabolism
Neoplasms / pathology
Protein Binding
Tumor Suppressor Protein p53 / genetics
Tumor Suppressor Protein p53 / metabolism*
Tumor Suppressor Protein p53 / physiology

Substances

Cellular Apoptosis Susceptibility Protein
DNA-Binding Proteins
Tumor Suppressor Protein p53